(Q34376230)

1 August 2017

1 reference

title

Physiopathology of bipolar disorders: what have changed in the last 10 years? (English)

1 reference

1 August 2017

1

Flávio Kapczinski

1 reference

1 August 2017

Benício Noronha Frey

2

1 reference

PubMed ID

15597134

1 August 2017

Vanessa Zannatto

series ordinal

3

1 reference

PubMed ID

15597134

1 August 2017

language of work or name

non-English

0 references

publication date

1 October 2004

1 reference

Brazilian Journal of Psychiatry

1 August 2017

1 reference

1 August 2017

26 Suppl 3

1 reference

1 August 2017

17-21

1 reference

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 August 2017

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Neurotransmitters and signal transduction processes in bipolar affective disorders: a synopsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Role of norepinephrine in the pathophysiology and treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Neural and behavioral substrates of mood and mood regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Cell pathology in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Neuroimaging in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Neuroprotective effects of lithium in cultured cells and animal models of diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Neurobiology of emotion perception I: The neural basis of normal emotion perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Neurobiology of emotion perception II: Implications for major psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

GABA and mood disorders: a brief review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Low plasma GABA is a trait-like marker for bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Brain metabolic alterations in medication-free patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Signaling: cellular insights into the pathophysiology of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Kindling and second messengers: an approach to the neurobiology of recurrence in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Signaling networks in the pathophysiology and treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Abnormal G protein alpha(s) - and alpha(i2)-subunit mRNA expression in bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Is CREB a key to neuronal survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Platelet membrane phospholipids in euthymic bipolar disorder patients: are they affected by lithium treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Enhanced protein kinase C activity and translocation in bipolar affective disorder brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Perspectives for the development of animal models of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Effects of lithium on an amphetamine animal model of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

The effects of lithium on a potential cycling model of bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Sleep deprivation in the rat: an animal model of mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Stressor-induced alterations in serotonergic activity in an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Behavioral withdrawal following several psychoactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Antidepressants selectively antagonize the hyperactivity induced in rats by long-term isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Depression: a new animal model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

Elucidation of the neurobiology of depression: insights from a novel genetic animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462004000700005

10.1590/S1516-44462004000700005

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

15597134